Evaluation of the safety and tolerability of a short higher-dose primaquine regimen for presumptive anti-relapse therapy in healthy subjects

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 105, Issue 10, 2011, Pages 568-573

  Ebringer, Andrew ^a   Heathcote, Gary ^b   Baker, Joanne ^a   Waller, Michael ^c   Shanks, G Dennis ^a   Edstein, Michael D ^a  

^a AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^b Robertson Barracks ^*  (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Malaria; Plasmodium vivax; Presumptive anti relapse therapy; Primaquine

Indexed keywords

4 (6 METHOXY 8 QUINOLYLAMINO)VALERIC ACID; ANTIHISTAMINIC AGENT; ATOVAQUONE PLUS PROGUANIL; DOXYCYCLINE; DRUG METABOLITE; PRIMAQUINE; PRIMAQUINE DERIVATIVE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ANXIETY; ARTHRALGIA; ARTICLE; BALANCE DISORDER; BLOOD CHEMISTRY; CLINICAL TRIAL; CONFUSION; CYANOSIS; DIARRHEA; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HALLUCINATION; HEMATOLOGICAL PARAMETERS; HUMAN; INSOMNIA; MALARIA; MALARIA CONTROL; MALE; MEMORY DISORDER; MYALGIA; NAUSEA; NORMAL HUMAN; OPEN STUDY; PATIENT COMPLIANCE; PERIPHERAL CYANOSIS; PRESUMPTIVE ANTIRELAPSE THERAPY; RELAPSE; RESPIRATORY DISTRESS; SHORT COURSE THERAPY; SIDE EFFECT; SOLDIER; URTICARIA; VOMITING;

ABDOMINAL PAIN; ADULT; ANTIMALARIALS; CYANOSIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEADACHE; HUMANS; INDONESIA; MALARIA, VIVAX; MALE; MILITARY PERSONNEL; NAUSEA; PATIENT COMPLIANCE; PRIMAQUINE; RECURRENCE; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

PLASMODIUM VIVAX;

EID: 80052968684     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.07.001     Document Type: Article

References (37)

1. Mendis K., Sina B.J., Marchesini P., Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 2001, 64:97-106.
2. Price R.N., Tjitra E., Guerra C.A., Yeung S., White N.J., Anstey N.M. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 2007, 77:79-87.
3. Baird J.K., Rieckmann K.H. Can primaquine therapy for vivax malaria be improved?. Trends Parasitol 2003, 19:115-120.
4. Baird J.K., Fryauff D.J., Hoffman S.L. Primaquine for prevention of malaria in travelers. Clin Infect Dis 2003, 37:1659-1667.
5. Hill D.R., Baird J.K., Parise M.E., Lewis L.S., Ryan E.T., Magill A.J. Primaquine: report from CDC Expert Meeting on Malaria Chemoprophylaxis I. Am J Trop Med Hyg 2006, 75:402-415.
6. Jelinek T., Nothdurft H.D., Von Sonnenburg F., Loscher T. Long-term efficacy of primaquine in the treatment of vivax malaria in nonimmune travelers. Am J Trop Med Hyg 1995, 52:322-324.
7. Alving A.S., Pullman T.N., et al. The clinical trial of 18 analogues of pamaquin (plasmochin) in vivax malaria, Chesson strain. J Clin Invest 1948, 27:34-45.
8. Bunnag D., Karbwang J., Thanavibul A., Chittamas S., Ratanapongse Y., Chalermrut K., et al. High dose of primaquine in primaquine resistant vivax malaria. Trans R Soc Trop Med Hyg 1994, 88:218-219.
9. Looareesuwan S., Buchachart K., Wilairatana P., Chalermrut K., Rattanapong Y., Amradee S., et al. Primaquine-tolerant vivax malaria in Thailand. Ann Trop Med Parasitol 1997, 91:939-943.
10. Smoak B.L., DeFraites R.F., Magill A.J., Kain K.C., Wellde B.T. Plasmodium vivax infections in U.S. army troops: failure of primaquine to prevent relapse in studies from Somalia. Am J Trop Med Hyg 1997, 56:231-234.
11. Schwartz E., Regev-Yochay G., Kurnik D. Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria. Am J Trop Med Hyg 2000, 62:393-395.
12. Duarte E.C., Pang L.W., Ribeiro L.C., Fontes C.J. Association of subtherapeutic dosages of a standard drug regimen with failures in preventing relapses of vivax malaria. Am J Trop Med Hyg 2001, 65:471-476.
13. Rajgor D.D., Gogtay N.J., Kadam V.S., Kamtekar K.D., Dalvi S.S., Chogle A.R., et al. Efficacy of a 14-day primaquine regimen in preventing relapses in patients with Plasmodium vivax malaria in Mumbai, India. Trans R Soc Trop Med Hyg 2003, 97:438-440.
14. Miura T., Kimura M., Koibuchi T., Endo T., Nakamura H., Odawara T., et al. Clinical characteristics of imported malaria in Japan: analysis at a referral hospital. Am J Trop Med Hyg 2005, 73:599-603.
15. Walsh D.S., Wilairatana P., Tang D.B., Heppner D.G., Brewer T.G., Krudsood S., et al. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse. Clin Infect Dis 2004, 39:1095-1103.
16. Rombo L., Edwards G., Ward S.A., Eriksson G., Lindquist L., Lindberg A., et al. Seven patients with relapses of Plasmodium vivax or P. ovale despite primaquine treatment. Trop Med Parasitol 1987, 38:49-50.
17. WHO Guidelines for the treatment of malaria 2010, World Health Organization, Geneva. 2nd ed.
18. Clayman C.B., Arnold J., Hockwald R.S., Yount E.H., Edgcomb J.H., Alving A.S. Toxicity of primaquine in Caucasians. J Am Med Assoc 1952, 149:1563-1568.
19. Clyde D.F. Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bull World Health Organ 1981, 59:391-395.
20. Fryauff D.J., Baird J.K., Basri H., Sumawinata I., Purnomo, Richie T.L., et al. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet 1995, 346:1190-1193.
21. Baird J.K., Lacy M.D., Basri H., Barcus M.J., Maguire J.D., Bangs M.J., et al. Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia. Clin Infect Dis 2001, 33:1990-1997.
22. Leslie T., Rab M.A., Ahmadzai H., Durrani N., Fayaz M., Kolaczinski J., et al. Compliance with 14-day primaquine therapy for radical cure of vivax malaria-a randomized placebo-controlled trial comparing unsupervised with supervised treatment. Trans R Soc Trop Med Hyg 2004, 98:168-173.
23. Clyde D.F., McCarthy V.C. Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine. Am J Trop Med Hyg 1977, 26:562-563.
24. Schmidt L.H., Fradkin R., Vaughan D., Rasco J. Radical cure of infections with Plasmodium cynomolgi: a function of total 8-aminoquinoline dose. Am J Trop Med Hyg 1977, 26:1116-1128.
25. Cooper W.C., Myatt A.V., Hernandez T., Jeffery G.M., Coatney G.R. Studies in human malaria. XXXI. Comparison of primaquine, isopentaquine, SN-3883, and pamaquine as curative agents against Chesson strain vivax malaria. Am J Trop Med Hyg 1953, 2:949-957.
26. Edgcomb J.H., Arnold J., Yount E.H., Alving A.S., Eichelberger L., Jeffery G.M., et al. Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report. J Natl Malar Soc 1950, 9:285-292.
27. Mihaly G.W., Ward S.A., Edwards G., Nicholl D.D., Orme M.L., Breckenridge A.M. Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size. Br J Clin Pharmacol 1985, 19:745-750.
28. Elmes N.J., Bennett S.M., Abdalla H., Carthew T.L., Edstein M.D. Lack of sex effect on the pharmacokinetics of primaquine. Am J Trop Med Hyg 2006, 74:951-952.
29. Mihaly G.W., Ward S.A., Edwards G., Orme M.L., Breckenridge A.M. Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. Br J Clin Pharmacol 1984, 17:441-446.
30. Cuong B.T., Binh V.Q., Dai B., Duy D.N., Lovell C.M., Rieckmann K.H., et al. Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects?. Br J Clin Pharmacol 2006, 61:682-689.
31. Binh V.Q., Chinh N.T., Thanh N.X., Cuong B.T., Quang N.N., Dai B., et al. Sex affects the steady-state pharmacokinetics of primaquine but not doxycycline in healthy subjects. Am J Trop Med Hyg 2009, 81:747-753.
32. Krudsood S., Tangpukdee N., Wilairatana P., Phophak N., Baird J.K., Brittenham G.M., et al. High-dose primaquine regimens against relapse of Plasmodium vivax malaria. Am J Trop Med Hyg 2008, 78:736-740.
33. Pukrittayakamee S., Imwong M., Chotivanich K., Singhasivanon P., Day N.P., White N.J. A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand. Am J Trop Med Hyg 2010, 82:542-547.
34. Dao N.V., Cuong B.T., Ngoa N.D., Thuy le T.T., The N.D., Duy D.N., et al. Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine. Trans R Soc Trop Med Hyg 2007, 101:534-539.
35. Chen N., Auliff A., Rieckmann K., Gatton M., Cheng Q. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J Infect Dis 2007, 195:934-941.
36. Coleman M.D., Coleman N.A. Drug-induced methaemoglobinaemia. Treatment issues. Drug Saf 1996, 14:394-405.
37. Hall A.H., Kulig K.W., Rumack B.H. Drug- and chemical-induced methaemoglobinaemia. Clinical features and management. Med Toxicol 1986, 1:253-260.